Trabectedin: Safety and Efficacy in the Treatment of Advanced Sarcoma

Clinical Medicine Insights: Oncology - New Zealand
doi 10.4137/cmo.s4907
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

SAGE Publications

Related search

Efficacy of Trabectedin in Advanced Soft Tissue Sarcoma: Beyond Lipo- And Leiomyosarcoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Role of Trabectedin in the Treatment of Soft Tissue Sarcoma

OncoTargets and Therapy
OncologyPharmacology
2009English

Trabectedin in the Treatment of Patients With Soft Tissue Sarcoma

Nowotwory
Cancer ResearchOncology
2018English

The Value of Trabectedin in the Treatment of Soft Tissue Sarcoma

Therapeutics and Clinical Risk Management
2016English

Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma

Dermatology and Therapy
Dermatology
2020English

The Danish Experience With Trabectedin Treatment for Metastatic Sarcoma: Importance of Hyponatremia

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2014English

Response to Trabectedin in a Patient With Advanced Synovial Sarcoma With Lung Metastases

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2014English

DGI-034 Evaluation of the Efficacy and Safety of Mifamurtide in Osteogenic Sarcoma Treatment in Paediatric Patients

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination With Anti-Igf Signaling Agents

Clinical Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy